Vertex Pharmaceuticals
VRTX
#128
Rank
$119.99 B
Marketcap
$464.92
Share price
-2.72%
Change (1 day)
31.96%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : $5.35 B

According to Vertex Pharmaceuticals's latest financial reports the company's total liabilities are $5.35 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vertex Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$5.14 B21.51%
2022-12-31$4.23 B27.18%
2021-12-31$3.33 B8.73%
2020-12-31$3.06 B37.25%
2019-12-31$2.23 B23.34%
2018-12-31$1.81 B20.42%
2017-12-31$1.50 B-3.52%
2016-12-31$1.55 B10.94%
2015-12-31$1.40 B13.44%
2014-12-31$1.23 B28.66%
2013-12-31$0.96 B-38.43%
2012-12-31$1.56 B22.55%
2011-12-31$1.27 B4.45%
2010-12-31$1.22 B42.17%
2009-12-31$0.85 B15.85%
2008-12-31$0.74 B124.6%
2007-12-31$0.33 B-20.56%
2006-12-31$0.41 B34.16%
2005-12-31$0.30 B-39.25%
2004-12-31$0.51 B-4.05%
2003-12-31$0.53 B21.6%
2002-12-31$0.43 B-2.81%
2001-12-31$0.44 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$35.38 B 560.43%๐Ÿ‡บ๐Ÿ‡ธ USA
$135.11 B 2,422.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$68.98 B 1,187.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$77.57 B 1,348.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$109.55 B 1,944.84%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.24 B-95.34%๐Ÿ‡บ๐Ÿ‡ธ USA